Understanding the Current and Future States of Cell and Gene Therapy Research
Explore the current and future landscape of gene therapy research, from advancements in oncology to strategies for improving review efficiency.
IBC
Cell & Gene Therapy vs Drug Research: What’s the Difference?
Cell and gene therapy’s popularity has grown exponentially in the past year. However, it’s important to understand how cell and gene therapy research is different from traditional drug development.
IBC Overview eLearning Module
Learn the essentials of institutional biosafety committees (IBCs), their role in research, and how they differ from IRBs in this eLearning module.
Improving Access to Research for Diverse and Underserved Populations
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
Discover how IQVIA and Advarra accelerated COVID-19 vaccine trials with IBC approvals in under two days, activating sites 71% faster.
What Is an Institutional Biosafety Committee?
An Institutional Biosafety Committee (IBC) evaluates risks in gene therapy research to ensure safety and compliance with NIH guidelines. Learn when IBC review is needed.
Q&A: FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
Study Startup Success for BioPharma and MedTech: Engage a Research Compliance Partner
A key element to successful study startup is identifying efficiencies to help meet critical milestones. Engaging with research compliance experts
The State of Clinical Trial Activation at Sites Report
Explore Advarra’s Study Activation Report to uncover roadblocks, survey findings, and solutions to streamline clinical trial activation at sites.
Meridian Builds Robust Gene Therapy Research Program
Discover how Meridian partnered with Advarra to ensure safety and streamline gene therapy research, including swift IBC approvals in just four days.
How Sites Can Win in the New Age of Genetically Engineered Treatments
With gene therapy trials on the rise, sites must prepare biosafety protocols, facility standards, and partnerships to attract cutting-edge studies.
mRNA and Its Role in Clinical Research
In the race to address the COVID-19 pandemic, researchers have worked tirelessly the past year to produce a vaccine. Operation